Collagen Supplement UK Statistics 2026: Market and Consumer Trends

The UK collagen supplement market is one of the fastest-growing categories in British wellness retail, generating an estimated $354-662 million in revenue in 2024 depending on scope of measurement, and projected to double in size by 2030 (Grand View Research, 2025; Mordor Intelligence, 2025). Collagen supplement UK statistics tell a story of rapid mainstream adoption - driven by an ageing population, social media amplification, and a genuine body of emerging clinical evidence. This page aggregates the most current, sourced market and consumer data available, updated July 2026, for journalists, researchers, and brand teams who need attributable UK figures.

The data here covers market size and growth trajectories, consumer demographics, product format breakdown, trend drivers, and the clinical evidence context. Every figure carries an inline citation and date. Where data gaps exist, we flag them explicitly.

The UK collagen market crossed a significant threshold in 2024, with revenue estimates from leading market research firms ranging from $354.8 million (Grand View Research, 2025) to $662 million (Mordor Intelligence, 2025) depending on whether the scope includes only dietary supplements or the full collagen value chain - which also covers medical biomaterials, cosmetics, and food and beverage applications.

For supplement-specific market data, the Grand View Research figure of $354.8 million in 2024 represents the more conservative and supplement-focused estimate. Mordor Intelligence's higher figure encompasses the total collagen category including NHS-adopted biomaterials, which is a materially different product set.

The directional picture is consistent across all research providers: the UK collagen market is growing at a CAGR of 6-10.5% annually over the 2025-2030 period (Grand View Research, 2025; Mordor Intelligence, 2025). This outpaces the broader UK dietary supplements market, which Grand View Research (2024) projects at 8.1% CAGR to 2033. The collagen supplement segment is a market outperformer within the broader supplement category.

For context, the UK dietary supplements market as a whole was estimated at $4.79 billion in 2024 (Grand View Research, 2024). Collagen represents approximately 7-14% of that total, depending on scope. That share has grown from an estimated 5% in 2018 as collagen moved from a specialist sports nutrition and clinical supplement into mainstream retail.

The growth trajectory has moderated slightly from the rapid 2020-2022 expansion period, when pandemic-era wellness spending accelerated the category significantly. Current CAGR projections of 6-10.5% represent mature, sustained growth rather than the exceptional growth of the post-pandemic period.

The UK collagen supplement consumer is not who the category started with. A decade ago, collagen supplementation was dominated by older adults - primarily women over 50 - seeking joint support and skin elasticity. That demographic picture has shifted substantially.

Women aged 25-65 now account for the largest share of UK collagen supplement consumption, with the 30-44 age group representing the single largest cohort (ITC Insights, 2024). This demographic shift is driven by two parallel trends: younger women entering the category earlier for preventative skin health and 'beauty from within' goals, and older women maintaining long-term supplementation routines.

Survey data from ITC Insights (2024) - drawn from consumers across multiple markets including the UK - found that 28% of female respondents cited skin health as a primary driver for supplement use. Among all UK adults, 42% take at least one supplement regularly (Grand View Research, 2024), with women more likely to supplement than men (47% versus 37%). The 25-34 age group shows the highest overall supplement uptake at 48%.

Men represent a smaller but growing share of the UK collagen market. Joint health and exercise recovery are the primary entry points for male consumers, rather than the skin and beauty goals that dominate female demand. A 2025 ITC survey of over 2,000 consumers found that 27% of respondents aged 45-59 reported using supplements specifically for beauty and skin health, up from 25% in 2024 (ITC Strategy, 2025). This trend is directionally consistent for the UK market, though UK-specific age-breakdown data remains limited in publicly accessible research.

Social media and influencer marketing have played a materially different role in collagen compared with most supplement categories. Liquid collagen shots and powder-format products are highly visual, photographable, and compatible with morning routine content - which has driven adoption among 25-34-year-olds who encounter the category via Instagram and TikTok before a health professional recommends it.

The product format landscape in UK collagen supplementation has consolidated around three primary formats, with powders now the dominant delivery mechanism by unit value.

Collagen powders account for 55-60% of UK retail collagen supplement unit sales by value in 2025 (Future Market Insights, 2025). This represents a significant shift from five years ago, when capsules were the dominant format among older supplement users and powders were associated primarily with sports nutrition. The rise of 'collagen coffee' and 'wellness latte' consumption occasions - adding a powder scoop to a morning coffee or matcha - has been a key driver of powder adoption in the 25-45 demographic.

Liquid collagen shots represent the fastest-growing format segment. Brands including Absolute Collagen, Revive Collagen, and Gold Collagen have built substantial UK direct-to-consumer businesses on the daily shot format, with subscription models that improve retention relative to powders. The liquid format's primary advantage is convenience and dose consistency - a pre-measured 10ml shot removes any uncertainty about quantity.

Marine collagen (sourced from fish skin and scales) has overtaken bovine (cattle-derived) as the largest single-source segment in UK retail, accounting for approximately 40-45% of retail value in 2025 (Future Market Insights, 2025) versus an estimated 30% in 2020. The shift is driven by three factors: rising vegetarian and pescatarian populations for whom bovine is less desirable; consumer perception that marine collagen is more 'natural' or premium; and the fact that marine collagen is predominantly Type I collagen - the type most directly associated with skin benefits, which is the dominant purchase driver.

Gummies represent a smaller but growing format, primarily reaching consumers who do not maintain a powder or liquid habit. Unit growth has been strong in the gummies segment, though average spend per unit is lower than powder or liquid formats, limiting value contribution.

Retail channels remain split between specialist health retailers (Holland & Barrett, independent health food stores), online direct-to-consumer (the primary channel for liquid shot brands), and mass-market pharmacy and grocery (Boots, Tesco, Sainsbury's own-label ranges). The NHS does not retail or recommend collagen supplements for general wellness - this distinction is addressed in the Efficacy section below.

Three macro trends are sustaining UK collagen supplement growth in 2026: demographic ageing, the beauty-from-within movement, and sport and recovery adoption.

Ageing population and skin health

The UK has an ageing population: the Office for National Statistics projects that 24% of the UK population will be aged 65 or over by 2043, up from 19% in 2022. Collagen production in human skin declines approximately 1-1.5% per year after age 30 (PMC, 2024), and by age 80, skin shows a 68% reduction in type I procollagen relative to 18-29-year-olds. This biological reality drives interest in supplementation among women in their 30s, 40s, and 50s who are actively managing skin health rather than simply treating existing signs of ageing.

Beauty from within

The 'beauty from within' or ingestible beauty segment is a distinct market driver. Global beauty supplements reached $3.68 billion in 2024 (Future Market Insights, 2025), and ingestible beauty nutraceuticals account for approximately 6.4% of the global nutraceutical market. Collagen is the anchor ingredient in this category - most ingestible beauty formulations are built around a collagen peptide base, with supporting ingredients such as hyaluronic acid, biotin, and vitamin C. The premium segment of the UK collagen market (products priced above £30 per monthly supply) grew from an estimated 25% of market value in 2020 to 35-40% in 2025 (MarkWide Research, 2025), which tracks directly with the beauty-from-within premium positioning adopted by liquid shot brands.

Sport, recovery, and longevity

Sports nutrition adoption of collagen is a more recent but fast-growing segment. Collagen peptides have been positioned as a joint and connective tissue support supplement for active consumers, with demand growing among runners, gym-goers, and the broader longevity-focused consumer demographic. A 2025 trial on collagen amino acid supplementation published in NPJ Aging (Nature, 2025) found reductions in biological age markers in human subjects, adding a longevity angle that is attracting a new wave of biohacking-oriented buyers who are not the traditional skin-health collagen consumer.

Collagen supplement growth in the UK is occurring ahead of, and in some cases despite, a still-developing evidence base. This is an important distinction for journalists, researchers, and informed consumers.

There is currently no EFSA-approved health claim specifically for collagen supplements and skin health in the UK or EU. EFSA (European Food Safety Authority) maintains the register of authorised nutrition and health claims under Regulation (EC) 1924/2006, which continues to apply in adapted form in the UK post-Brexit. Collagen-specific skin claims have not been granted Article 13.5 status as of 2025 (EFSA Health Claims Register).

This does not mean collagen supplementation is without clinical support - it means the evidence base has not yet met the regulatory threshold for an approved claim. The picture from recent peer-reviewed research is more nuanced:

For skin outcomes, a 2025 systematic review and meta-analysis published in The American Journal of Medicine (ScienceDirect, 2025) analysed randomised controlled trials on collagen supplements and skin ageing, finding statistically significant improvements in skin hydration, elasticity, and wrinkling. A 2024 clinical trial in Dermatology Research and Practice found improvements in skin collagen, hydration, elasticity, and scalp/hair condition after 12 weeks of hydrolysed collagen supplementation (Wiley, 2024). These are positive findings, though researchers consistently note that studies are often industry-funded and sample sizes remain modest.

For joint outcomes, a 2024 trial sequential meta-analysis confirmed small-to-moderate effect sizes on pain and function with strong aggregate evidence for hydrolysed collagen and joint health (PMC, 2024). Joint health claims are the area where the evidence base is furthest developed, yet even here, effect sizes are modest rather than dramatic.

The honest summary: the emerging research direction is favourable for collagen supplementation, particularly for skin hydration, elasticity, and joint pain in at-risk populations. The evidence is not yet strong enough for EFSA-approved claims, and consumers should be cautious of product-level marketing that presents benefit as established fact. Independent sources such as the NHS evidence on supplements and the British Dietetic Association (BDA) remain the most reliable reference points for UK consumers seeking unbiased efficacy assessment.

For a deeper review of the clinical evidence on whether collagen supplementation works, see our article on does collagen work.

The UK collagen supplement market in 2026 is characterised by maturation in core formats, format innovation in adjacent segments, and a gradual tightening of the regulatory and evidence environment.

Powder format growth has moderated from the rapid 2020-2022 expansion, with unit growth slowing to mid-single digits. The primary volume growth is coming from liquid shots and format innovation - gummies, collagen-infused protein bars, and ready-to-drink beverages. The 'collagen coffee' occasion has become a stable consumer behaviour rather than a trend, which is a positive signal for long-term category retention.

Mordor Intelligence (2025) projects the total UK collagen market (including all applications) at $662.25 million in 2025, growing to $897.84 million by 2031 at a 6.27% CAGR. Grand View Research (2025) projects the supplement-specific segment reaching $637.5 million by 2030, implying a CAGR of 10.5% from the supplement base. The divergence between these projections reflects different scope definitions rather than genuine analytical disagreement.

The regulatory picture is worth monitoring. The UK Medicines and Healthcare products Regulatory Agency (MHRA) and Food Standards Agency (FSA) are actively reviewing the boundary between food supplements and quasi-medical claims. A brand making aggressive skin-reversal claims for a collagen supplement risks regulatory challenge. Brands that maintain ingredient-level claims (supports skin hydration, contributes to joint comfort) rather than condition-treatment framing are more defensible.

The longevity angle - collagen supplementation positioned as a biological age intervention - is emerging as the next growth narrative. The 2025 NPJ Aging study (Nature, 2025) attracted significant media coverage and may accelerate male adoption in the 40-60 demographic, which currently represents an underserved segment relative to the female-dominant market.

This article aggregates publicly available market research, peer-reviewed clinical studies, and consumer survey data on the UK collagen supplement market. All statistics include an inline source citation and date. Where data gaps exist, we flag them explicitly.

Data sources and scope:

Market size and growth projections - sourced from market research firm preview pages and press releases: Grand View Research (2025), Mordor Intelligence (2025), Future Market Insights (2025), MarkWide Research (2025), 6W Research (2025). Different firms use different scope definitions - some include medical biomaterials, cosmetics, and food and beverage in their 'collagen market' figures, others restrict to dietary supplements only. Where scope is unclear, we note the reporting range rather than presenting a single figure.

Consumer demographics - sourced from ITC Insights 2024 Consumer Supplement Survey; ITC Strategy 2025 survey (2,000+ consumers, December 2024-January 2025); Grand View Research UK dietary supplements consumer data (2024).

Clinical evidence - sourced exclusively from peer-reviewed publications: PMC/NCBI (National Center for Biotechnology Information), The American Journal of Medicine (ScienceDirect), Dermatology Research and Practice (Wiley, 2024), NPJ Aging (Nature, 2025).

Regulatory context - EFSA Health Claims Register; UK Food Standards Agency; UK Food Supplements Regulations 2003.

Data gaps explicitly flagged:

UK-specific collagen supplement revenue in sterling (GBP) is not published in publicly available market research - all major providers report in USD. GBP equivalents are not provided here due to exchange rate uncertainty. Age and gender demographic breakdowns for UK-specific collagen supplement use are not published by ONS or NHS data sets - consumer survey data is the best available proxy. Individual brand revenue figures are not publicly disclosed by UK collagen brands. Pre-2020 UK market size data is limited; historical trend comparisons use estimates derived from CAGR back-calculations.

Last updated: July 2026. We review and update this page annually.